Hypotensive lipid-containing biodegradable intraocular implants and related methods
Biocompatible intraocular implants include a prostamide component and a biodegradable polymer that is effective in facilitating release of the prostamide component into an eye for an extended period of time. The prostamide component may be associated with a biodegradable polymer matrix, such as a ma...
Saved in:
Main Author | |
---|---|
Format | Patent |
Language | English |
Published |
25.06.2019
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Biocompatible intraocular implants include a prostamide component and a biodegradable polymer that is effective in facilitating release of the prostamide component into an eye for an extended period of time. The prostamide component may be associated with a biodegradable polymer matrix, such as a matrix of a two biodegradable polymers. The implants may be placed in an eye to treat or reduce at least one symptom of an ocular condition, such as glaucoma. |
---|---|
Bibliography: | Application Number: US201715693180 |